A centronuclear myopathy-dynamin 2 mutation impairs skeletal muscle structure and function in mice

Human Molecular Genetics

Volumn 19, Issue 24, 2010, Pages 4820-4836

  Durieux, Anne Cécile ^a,b,c,d   Vignaud, Alban ^a,b,c,d   Prudhon, Bernard ^a,b,c,d   Viou, Mai Thao ^a,b,c,d   Beuvin, Maud ^a,b,c,d   Vassilopoulos, Stéphane ^a,b,c,d   Fraysse, Bodvaël ^a,b,c,d   Ferry, Arnaud ^a,b,c,d   Lainé, Jeanne ^a,b,c,d   Romero, Norma B ^a,b,c,d,e   Guicheney, Pascale ^a,f   Bitoun, Marc ^a,b,c,d  

^a SORBONNE UNIVERSITÉ   (France)

^b CNRS   (France)

^c Sorbonne Université   (France)

^d Institut de Myologie   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DYNAMIN II; DYSFERLIN; UBIQUITIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; CELL MIGRATION; EMBRYO; EMBRYO CELL; FIBROBLAST; GENE EXPRESSION; GENE MUTATION; HETEROZYGOSITY; HISTOPATHOLOGY; HOMOZYGOSITY; MITOCHONDRION; MOUSE; MUSCLE CELL; MUSCLE CONTRACTION; MUSCLE FUNCTION; MUSCULAR DYSTROPHY; MYOPATHY; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE; TEMPORALIS MUSCLE; UPREGULATION; WEANING; WILD TYPE;

ANIMALS; BEHAVIOR, ANIMAL; CALCIUM; DYNAMIN II; EMBRYO, MAMMALIAN; FIBROBLASTS; HETEROZYGOTE; HOMOZYGOTE; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; MOTOR ACTIVITY; MUSCLE CONTRACTION; MUSCLE PROTEINS; MUSCLE WEAKNESS; MUSCLE, SKELETAL; MUSCULAR ATROPHY; MUTATION; MYOPATHIES, STRUCTURAL, CONGENITAL; PHENOTYPE; PROTEIN TRANSPORT; SUBCELLULAR FRACTIONS;

MUS;

EID: 78649471271     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddq413     Document Type: Article

References (45)

1. Jungbluth, H., Wallgren-Pettersson, C. and Laporte, J. (2008) Centronuclear (myotubular) myopathy. Orphanet J. Rare Dis., 3, 26.
2. Bitoun, M., Maugenre, S., Jeannet, P.Y., Lacene, E., Ferrer, X., Laforet, P., Martin, J.J., Laporte, J., Lochmuller, H. and Beggs, A.H. et al. (2005) Mutations in dynamin 2 cause dominant centronuclear myopathy. Nat. Genet., 37, 1207-1209.
3. Bitoun, M., Bevilacqua, J.A., Prudhon, B., Maugenre, S., Taratuto, A.L., Monges, S., Lubieniecki, F., Cances, C., Uro-Coste, E. and Mayer, M. et al. (2007) Dynamin 2 mutations cause sporadic centronuclear myopathy with neonatal onset. Ann. Neurol., 62, 666-670.
4. Fischer, D., Herasse, M., Bitoun, M., Barragan-Campos, H.M., Chiras, J., Laforet, P., Fardeau, M., Eymard, B., Guicheney, P. and Romero, N.B. (2006) Characterization of the muscle involvement in dynamin 2-related centronuclear myopathy. Brain, 129, 1463-1469.
5. Schessl, J., Medne, L., Hu, Y., Zou, Y., Brown, M.J., Huse, J.T., Torigian, D.A., Jungbluth, H., Goebel, H.H. and Bonnemann, C.G. (2007) MRI in DNM2-related centronuclear myopathy: evidence for highly selective muscle involvement. Neuromuscul. Disord., 17, 28-32.
6. Romero, N.B. (2010) Centronuclear myopathies: a widening concept. Neuromuscul. Disord., 20, 223-228.
7. Fabrizi, G.M., Ferrarini, M., Cavallaro, T., Cabrini, I., Cerini, R., Bertolasi, L. and Rizzuto, N. (2007) Two novel mutations in dynamin-2 cause axonal Charcot-Marie-Tooth disease. Neurology, 69, 291-295.
8. Züchner, S., Noureddine, M., Kennerson, M., Verhoeven, K., Claeys, K., De Jonghe, P., Merory, J., Oliveira, S.A., Speer, M.C. and Stenger, J.E. et al. (2005) Mutations in the pleckstrin homology domain of dynamin 2 cause dominant intermediate Charcot-Marie-Tooth disease. Nat. Genet., 37, 289-294.
9. Susman, R.D., Quijano-Roy, S., Yang, N., Webster, R., Clarke, N.F., Dowling, J., Kennerson, M., Nicholson, G., Biancalana, V. and Ilkovski, B. et al. (2010) Expanding the clinical, pathological and MRI phenotype of DNM2-related centronuclear myopathy. Neuromuscul. Disord., 20, 229-237.
10. Cook, T.A., Urrutia, R. and McNiven, M.A. (1994) Identification of dynamin 2, an isoform ubiquitously expressed in rat tissues. Proc. Natl Acad. Sci. USA, 91, 644-648.
11. Praefcke, G.J. and McMahon, H.T. (2004) The dynamin superfamily: universal membrane tubulation and fission molecules? Nat. Rev. Mol. Cell Biol., 5, 133-147.
12. Durieux, A.C., Prudhon, B., Guicheney, P. and Bitoun, M. (2010) Dynamin 2 and human diseases. J. Mol. Med., 88, 339-350.
13. Bitoun, M., Durieux, A.C., Prudhon, B., Bevilacqua, J.A., Herledan, A., Sakanyan, V., Urtizberea, A., Cartier, L., Romero, N.B. and Guicheney, P. (2009) Dynamin 2 mutations associated with human diseases impair clathrin-mediated receptor endocytosis. Hum. Mutat., 30, 1419-1427.
14. Tanabe, K. and Takei, K. (2009) Dynamic instability of microtubules requires dynamin 2 and is impaired in a Charcot-Marie-Tooth mutant. J. Cell Biol., 185, 939-48.
15. Henley, J.R., Krueger, E.W., Oswald, B.J. and McNiven, M.A. (1998) Dynamin-mediated internalization of caveolae. J. Cell Biol., 141, 85-99.
16. Glass, D.J. (2003) Molecular mechanisms modulating muscle mass. Trends Mol. Med., 9, 344-350.
17. Lecker, S.H., Jagoe, R.T., Gilbert, A., Gomes, M., Baracos, V., Bailey, J., Price, S.R., Mitch, W.E. and Goldberg, A.L. (2004) Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J., 18, 39-51.
18. Sacheck, J.M., Hyatt, J.P., Raffaello, A., Jagoe, R.T., Roy, R.R., Edgerton, V.R., Lecker, S.H. and Goldberg, A.L. (2007) Rapid disuse and denervation atrophy involve transcriptional changes similar to those of muscle wasting during systemic diseases. FASEB J., 21, 140-155.
19. Sandri, M. (2008) Signaling in muscle atrophy and hypertrophy. Physiology (Bethesda), 23, 160-170.
20. Bodine, S.C., Latres, E., Baumhueter, S., Lai, V.K., Nunez, L., Clarke, B.A., Poueymirou, W.T., Panaro, F.J., Na, E. and Dharmarajan, K. et al. (2001) Identification of ubiquitin ligases required for skeletal muscle atrophy. Science, 294, 1704-1708.
21. Sandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K., Schiaffino, S., Lecker, S.H. and Goldberg, A.L. (2004) Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell, 117, 399-412.
22. Zhao, J., Brault, J.J., Schild, A., Cao, P., Sandri, M., Schiaffino, S., Lecker, S.H. and Goldberg, A.L. (2007) FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. Cell Metab., 6, 472-483.
23. Kramerova, I., Kudryashova, E., Venkatraman, G. and Spencer, M.J. (2005) Calpain 3 participates in sarcomere remodeling by acting upstream of the ubiquitin-proteasome pathway. Hum. Mol. Genet., 14, 2125-2134.
24. Du, J., Wang, X., Miereles, C., Bailey, J.L., Debigare, R., Zheng, B., Price, S.R. and Mitch, W.E. (2004) Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions. J. Clin. Invest., 113, 115-123.
25. Towler, M.C., Kaufman, S.J. and Brodsky, F.M. (2004) Membrane traffic in skeletal muscle. Traffic, 5, 129-139.
26. Bugnard, E., Zaal, K.J. and Ralston, E. (2005) Reorganization of microtubule nucleation during muscle differentiation. Cell Motil. Cytoskeleton, 60, 1-13.
27. Tassin, A.M., Maro, B. and Bornens, M. (1985) Fate of microtubule-organizing centers during myogenesis in vitro. J. Cell Biol., 100, 35-46.
28. Wang, L., Barylko, B., Byers, C., Ross, J.A., Jameson, D.M. and Albanesi, J.P. (2010) Dynamin 2mutants linked to centronuclearmyopathies form abnormally stable polymers. J. Biol. Chem., 285, 22753-22757.
29. Lee, E., Marcucci, M., Daniell, L., Pypaert, M., Weisz, O.A., Ochoa, G.C., Farsad, K., Wenk, M.R. and De Camilli, P. (2002) Amphiphysin 2 (Bin1) and T-tubule biogenesis in muscle. Science, 297, 1193-1196.
30. Razzaq, A., Robinson, I.M., McMahon, H.T., Skepper, J.N., Su, Y., Zelhof, A.C., Jackson, A.P., Gay, N.J. and O'Kane, C.J. (2001) Amphiphysin is necessary for organization of the excitation-contraction coupling machinery of muscles, but not for synaptic vesicle endocytosis in Drosophila. Genes Dev., 15, 2967-2979.
31. Buj-Bello, A., Fougerousse, F., Schwab, Y., Messaddeq, N., Spehner, D., Pierson, C.R., Durand, M., Kretz, C., Danos, O. and Douar, A.M. et al. (2008) AAV-mediated intramuscular delivery of myotubularin corrects the myotubular myopathy phenotype in targeted murine muscle and suggests a function in plasma membrane homeostasis. Hum. Mol. Genet., 17, 2132-2143.
32. Dowling, J.J., Vreede, A.P., Low, S.E., Gibbs, E.M., Kuwada, J.Y., Bonnemann, C.G. and Feldman, E.L. (2009) Loss of myotubularin function results in T-tubule disorganization in zebrafish and human myotubular myopathy. PLoS Genet., 5, e1000372.
33. Al-Qusairi, L., Weiss, N., Toussaint, A., Berbey, C., Messaddeq, N., Kretz, C., Sanoudou, D., Beggs, A.H., Allard, B. and Mandel, J.L. et al. (2009) T-tubule disorganization and defective excitation-contraction coupling in muscle fibers lacking myotubularin lipid phosphatase. Proc. Natl Acad. Sci. USA, 106, 18763-18768.
34. Glover, L. and Brown, R.H. (2007) Dysferlin in membrane trafficking and patch repair. Traffic, 8, 785-794.
35. Capanni, C., Sabatelli, P., Mattioli, E., Ognibene, A., Columbaro, M., Lattanzi, G., Merlini, L., Minetti, C., Maraldi, N.M. and Squarzoni, S. (2003) Dysferlin in a hyperCKaemic patient with caveolin 3 mutation and in C2C12 cells after p38 MAP kinase inhibition. Exp. Mol. Med., 35, 538-544.
36. Matsuda, C., Hayashi, Y.K., Ogawa, M., Aoki, M., Murayama, K., Nishino, I., Nonaka, I., Arahata, K. and Brown, R.H. Jr (2001) The sarcolemmal proteins dysferlin and caveolin-3 interact in skeletal muscle. Hum. Mol. Genet., 10, 1761-1766.
37. Ferguson, S.M., Raimondi, A., Paradise, S., Shen, H., Mesaki, K., Ferguson, A., Destaing, O., Ko, G., Takasaki, J. and Cremona, O. et al. (2009) Coordinated actions of actin and BAR proteins upstream of dynamin at endocytic clathrin-coated pits. Dev. Cell, 17, 811-822.
38. Mitsunari, T., Nakatsu, F., Shioda, N., Love, P.E., Grinberg, A., Bonifacino, J.S. and Ohno, H. (2005) Clathrin adaptor AP-2 is essential for early embryonal development. Mol. Cell Biol., 25, 9318-9323.
39. Ohno, H. (2006) Physiological roles of clathrin adaptor AP complexes: lessons from mutant animals. J. Biochem., 139, 943-948.
40. Ferguson, S.M., Brasnjo, G., Hayashi, M., Wolfel, M., Collesi, C., Giovedi, S., Raimondi, A., Gong, L.W., Ariel, P. and Paradise, S. et al. (2007) A selective activity-dependent requirement for dynamin 1 in synaptic vesicle endocytosis. Science, 316, 570-574.
41. Turgeon, B. and Meloche, S. (2009) Interpreting neonatal lethal phenotypes in mouse mutants: insights into gene function and human diseases. Physiol. Rev., 89, 1-26.
42. Dubowitz, V. and Sewry, C. (2007) Muscle Biopsy. A Practical Approach, 3rd edn. W.B. Saunders/Elsevier, London, Philadelphia, pp. 21-39.
43. Fraysse, B., Liantonio, A., Cetrone, M., Burdi, R., Pierno, S., Frigeri, A., Pisoni, M., Camerino, C. and De Luca, A. (2004) The alteration of calcium homeostasis in adult dystrophic mdx muscle fibers is worsened by a chronic exercise in vivo. Neurobiol. Dis., 17, 144-154. doi:10.1016/j.nbd.2004.06.002
44. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem., 260, 3440-3450.
45. Trollet, C., Anvar, S.Y., Venema, A., Hargreaves, I.P., Foster, K., Vignaud, A., Ferry, A., Negroni, E., Hourde, C. and Baraibar, M.A. et al. (2010) Molecular and phenotypic characterization of a mouse model of oculopharyngeal muscular dystrophy reveals severe muscular atrophy restricted to fast glycolytic fibres. Hum. Mol. Genet., 19, 2191-2207.